Health Care and Biotech

The Chartist reports the technicals are lining up for CSL to gather momentum to the upside.

Sonic Healthcare is the second pathology provider to issue an earnings downgrade in a week, as funding cuts pressure the industry.

Private hospital operator Healthscope is expected to weather insurer rate reductions, given its margins are among the highest in the sector. Morgan Stanley initiates coverage.

Osprey Medical is making progress with a device to minimise kidney damage when dyes are extensively used in X-ray procedures.

Most brokers expect newly listed Medibank Private to deliver on prospectus forecasts but remain concerned about the outlook for FY16.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. JP Morgan has decided it’s time to be more upbeat about Cochlear Ltd, given the company appears to be taking back market share.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Not only is a four-flu vaccine better than a three-flu, it’s 50% more pricey and thus offers a big boost to CSL earnings, UBS points out, which has been overlooked by the market.

Equity strategy; Coles extends lead on Woolworths; Overseas holidays; automotive dealers; pharma wholesalers; banking fee growth; Donaco update.

Ukraine crops; REA Group vs Domain; WA miners counting costs; home builders buoyant; views on Nib Holdings, Yowie Group; outlook for shopping centres.

Sonic Healthcare will acquire Switzerland’s Medisupport, a deal welcomed by most brokers for the synergies it offers to the European business.